Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients

Medical Science Monitor

Volumn 14, Issue 6, 2008, Pages

  Escher, Felicitas ^a   Kühl, Uwe ^a   Sabi, Titus ^a   Suckau, Lennart ^a   Lassner, Dirk ^b   Poller, Wolfgang ^a   Schultheiss, Heinz Peter ^a   Noutsias, Michel ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institute of Cardiac Diagnostics and Therapy (IKDT)   (Germany)

Author keywords

Diagnosis; Dilated cardiomyopathy; Immunohistochemistry; Parvovirus B19; PCR

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLASMID DNA;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; FEMALE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION; VIRUS MYOCARDITIS;

ADULT; ANTIBODIES, VIRAL; BIOPSY; CAPSID PROTEINS; CARDIOMYOPATHY, DILATED; CELL LINE; ENDOCARDIUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENOME, VIRAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; TRANSFECTION; VIRAL LOAD;

EID: 46449126008     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. D'Ambrosio A, Patti C, Manzoli A et al: The fate of myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review Heart, 2001; 85: 499-504
2. Liu P, Martino T, Opavsky MA, Penninger J: Viral myocarditis: balance between viral infection and immune response. Can J Cardiol, 1996; 12: 935-43.
3. Kuhl U, Pauschinger M, Bock T et al: Parvovirus B19 infection mimicking acute myocardial infarction. Circulation, 2003; 108: 945-50
4. Kuhl U, Pauschinger M, Noutsias M et al: High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventrucular dysfunction. Circulation, 2005; 111: 887-93.
5. Kuhl U, Pauschinger M, Seeberg B et al: Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation, 2005; 112: 1965-70
6. Noutsias M, Seeberg B, Schultheiss HP, Kuhl U: Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation, 1999; 99: 2124-31
7. Noutsias M, Pauschinger M, Schultheiss HP, Kuhl U: Cytotoxic perforin+ and T1A-1+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy. Eur J Heart Fail, 2003; 5: 469-79
8. Noutsias M, Pauschinger M, Schultheiss H, Kuhl U: Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Med Sci Monit, 2002; 8(7): CR478-87
9. Sabattini E, Bisgaard K, Ascard S et al: The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol, 1998; 51: 506-11
10. Noutsias M, Fechner H, de Jonge H et al: Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy implications for cardiotropic viral infections. Circulation, 2001; 104: 275-80
11. Noutsias M, Pauschinger M, Ostermann K et al: Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. Med Sci Monit, 2002; 8(5): MT59-71
12. Li Y, Bourlet T, Andreoletti L et al: Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy. Circulation, 2000; 101: 231-34
13. Dettmeyer R, Bassner A, Schlamann M et al: Role of virus-induced myocardial affections in sudden infant death syndrome: a prospective post-mortem study. Pediatr Res, 2004; 55: 947-52
14. Vadlamudi C, Rezuke WN, Ross JW et al: The use of monoclonal antibody R92-F6 and polymerase chain reaction to confirm the presence of parvovirus B19 in bone marrow specimens of patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med, 1999; 123: 768-73
15. Loughrey AC, O'Neill HJ, Coyle PV, DeLeys R: Identification and use of a neutralising epitope of parvovirus B19 for the rapid detection of virus infection. J Med Virol, 1993; 39: 97-100
16. Morey AL, Ferguson DJ, Fleming KA: Combined immunocytochemistry and non-isotopic in situ hybridization for the ultrastructural investigation of human parvovirus B19 infection. Histochem J. 1995; 27: 46-53
17. O'Neill HJ, Coyle PV: Two anti-parvovirus B 19 IgM capture assays incorporating a mouse monoclonal antibody specific for B 19 viral capsid proteins VP 1 and VP 2. Arch Virol, 1992; 123: 125-34
18. Chen S, Howard O: Images in clinical medicine. Parvovirus B19 infection. N Engl J Med, 2004; 350: 598
19. Young NS, Brown KE: Parvovirus B19. N Engl J Med, 2004; 350: 586-97
20. Takahashi Y, Murai C, Shibata S et al: Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA. 1998; 95: 8227-32
21. Wang X, Zhang C, Liu F et al: Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart disease indicated by nested PCR and in situ hybridization. J Clin Virol, 2004; 31: 20-24
22. Dorsch S, Liebisch G, Kaufmann B et al: The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol, 2002; 76: 2014-18
23. Escher F, Modrow S, Sabi T et al: Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic-dilated cardiomyopathy. Med Sci Monit, 2008; in press
24. Streitz M, Noutsias M, Volkmer R et al: NS1 Specific CD8+ T-cells with Effector Function and TRBV11 Dominance in a Patient with Parvovirus B19 Associated Inflammatory Cardiomyopathy. PLoS One, 2008; in press